Literature DB >> 15756044

Erythrocyte antioxidant enzymes in Parkinson's disease.

S Abraham1, C C Soundararajan, S Vivekanandhan, M Behari.   

Abstract

BACKGROUND &
OBJECTIVES: Oxidative stress is incriminated to play a central role in the pathogenesis of Parkinson's disease (PD). Oxidative stress, to which neurons are highly susceptible, is also known to induce oxidative changes in human red blood cells (RBCs), in vivo and in vitro. Earlier studies on oxidative stress in RBCs in patients with PD have yielded controversial results claiming unaltered activity to reduced activity. Using RBC as a model, we have undertaken this study to ascertain the possibility of oxidative damage to the RBCs in PD by measuring the cytosolic antioxidant enzymes viz., superoxide dismutase (SOD), catalase (CAT) glutathione peroxidase (G-Px) and glucose-6-phosphate dehydrogenase (G6PD).
METHODS: Activities of antioxidant enzymes were measured in erythrocytes of 115 PD patients and 37 normal age-matched healthy persons as controls. Enzymes activities were correlated with age of patients, age of onset of disease, duration of disease, United Parkinson's Disease Rating Scale (UPDRS) and Hoehn and Yahr stage.
RESULTS: The SOD, CAT, G-Px and G6PD activities were significantly lower in patients with PD compared to the control. A significant (P<0.05) negative correlation of enzyme activities with Hoehn and Yahr stage of the disease and also with UPDRS score was found. INTERPRETATION &amp;
CONCLUSION: Results of the present study showed involvement of oxidative stress as one of the risk factors, which can initiate and/or promote neurodegeneration in PD and was correlated to the severity of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15756044

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  29 in total

1.  Exosomes as drug delivery vehicles for Parkinson's disease therapy.

Authors:  Matthew J Haney; Natalia L Klyachko; Yuling Zhao; Richa Gupta; Evgeniya G Plotnikova; Zhijian He; Tejash Patel; Aleksandr Piroyan; Marina Sokolsky; Alexander V Kabanov; Elena V Batrakova
Journal:  J Control Release       Date:  2015-03-31       Impact factor: 9.776

2.  Glucose-6-phosphate dehydrogenase activity in Parkinson's disease.

Authors:  Lin Gao; Pablo Mir; Francisco J Díaz-Corrales; Rebeca Mejías; Fátima Carrillo; Pablo J Vime; Juan Díaz-Martín; Alfredo Palomino; Manuel Carballo; Elizabeth Pintado; Miguel Lucas; José López-Barneo
Journal:  J Neurol       Date:  2008-12-08       Impact factor: 4.849

Review 3.  Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.

Authors:  Dhruvitkumar S Sutaria; Mohamed Badawi; Mitch A Phelps; Thomas D Schmittgen
Journal:  Pharm Res       Date:  2017-03-17       Impact factor: 4.200

4.  Dysregulation of Intracellular Ca2+ in Dystrophic Cortical and Hippocampal Neurons.

Authors:  José R Lopez; Juan Kolster; Arkady Uryash; Eric Estève; Francisco Altamirano; José A Adams
Journal:  Mol Neurobiol       Date:  2016-12-15       Impact factor: 5.590

5.  Neuroprotection by transgenic expression of glucose-6-phosphate dehydrogenase in dopaminergic nigrostriatal neurons of mice.

Authors:  Rebeca Mejías; Javier Villadiego; C Oscar Pintado; Pablo J Vime; Lin Gao; Juan J Toledo-Aral; Miriam Echevarría; José López-Barneo
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

Review 6.  Delivery of Therapeutic Proteins via Extracellular Vesicles: Review and Potential Treatments for Parkinson's Disease, Glioma, and Schwannoma.

Authors:  Justin Hall; Shilpa Prabhakar; Leonora Balaj; Charles P Lai; Richard A Cerione; Xandra O Breakefield
Journal:  Cell Mol Neurobiol       Date:  2016-03-26       Impact factor: 5.046

7.  Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson's disease.

Authors:  Burcu Gökçe Çokal; Mustafa Yurtdaş; Selda Keskin Güler; Hafize Nalan Güneş; Ceyla Ataç Uçar; Bilal Aytaç; Zahide Esra Durak; Tahir Kurtuluş Yoldaş; İlker Durak; Hikmet Can Çubukçu
Journal:  Neurol Sci       Date:  2016-11-30       Impact factor: 3.307

8.  Blood-borne macrophage-neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery.

Authors:  Matthew J Haney; Poornima Suresh; Yuling Zhao; Georgette D Kanmogne; Irena Kadiu; Marina Sokolsky-Papkov; Natalia L Klyachko; R Lee Mosley; Alexander V Kabanov; Howard E Gendelman; Elena V Batrakova
Journal:  Nanomedicine (Lond)       Date:  2012-01-11       Impact factor: 5.307

9.  A macrophage-nanozyme delivery system for Parkinson's disease.

Authors:  Elena V Batrakova; Shu Li; Ashley D Reynolds; R Lee Mosley; Tatiana K Bronich; Alexander V Kabanov; Howard E Gendelman
Journal:  Bioconjug Chem       Date:  2007-08-31       Impact factor: 4.774

Review 10.  Superoxide dismutases: a physiopharmacological update.

Authors:  A Valdivia; S Pérez-Alvarez; J D Aroca-Aguilar; I Ikuta; J Jordán
Journal:  J Physiol Biochem       Date:  2009-06       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.